Saudi Arabia denies approving camel urine-derived drug to treat cancer
Dubai: Saudi Arabia's Food and Drug Authority (SFDA) has denied claims circulating on social media that it approved a medicine derived from active substances in camel urine for the treatment of cancer. In a statement posted on its official X account, the authority said the claims were false, clarifying that the product in question was registered as a dietary supplement rather than a medicine…
We haven't written up this one. Gulf News has the full story — the link below goes straight to it.
